VINCENT LEWIS: Open Payments
NPI 1275791147 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 74 payments from 19 companies in 2025. Trend: 2023 $1,488 · 2024 $1,481 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $168 |
| Novo Nordisk Inc | 8 | $150 |
| PFIZER INC. | 12 | $149 |
| Phathom Pharmaceuticals, Inc. | 10 | $126 |
| GlaxoSmithKline, LLC. | 6 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Exact Sciences Corporation | 3 | $67 |
| ABBVIE INC. | 3 | $61 |
| Amgen Inc. | 3 | $52 |
Products named: VOQUEZNA, MOUNJARO, TRELEGY ELLIPTA, LEQVIO, BREZTRI, Cologuard Collection Kit, Ozempic, Wegovy.
Industry payments across MD — which companies pay providers there.
